Frequently Asked Questions about Pacific Biosciences of California, Inc. (PACB)

Name: Pacific Biosciences of California, Inc. (PACB) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Pacific Biosciences of California, Inc. (PACB) do?

Accepted Answer

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-tim...

Question 2

Is Pacific Biosciences of California, Inc. (PACB) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of PACB reveals an Altman Z-Score of -6.07 and a Piotroski F-Score of 3/9. These metrics, combined with its 5-year revenue trend ($0.16B most recent), help investors decide if PACB fits their risk profile.

Question 3

What is the current P/E ratio for PACB?

Accepted Answer

As of the latest trading session, Pacific Biosciences of California, Inc. (PACB) has a trailing P/E ratio of -0.78.

Question 4

Who is the CEO of Pacific Biosciences of California, Inc.?

Accepted Answer

The current Chief Executive Officer of Pacific Biosciences of California, Inc. is Christian O. Henry.

Question 5

What was PACB's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Pacific Biosciences of California, Inc. reported annual revenues of $0.16B (2025), $0.15B (2024), $0.20B (2023), $0.13B (2022), $0.13B (2021) respectively.

Question 6

Does PACB pay a dividend?

Accepted Answer

Pacific Biosciences of California, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does PACB have?

Accepted Answer

In its latest reporting period, Pacific Biosciences of California, Inc. generated $-0.11B in Free Cash Flow against a total debt load of $0.76B.

Question 8

What is the Price-to-Book (P/B) ratio of Pacific Biosciences of California, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Pacific Biosciences of California, Inc. (PACB) is currently 80.15.

Question 9

What is the Price-to-Sales (P/S) ratio of PACB?

Accepted Answer

Based on trailing twelve-month data, Pacific Biosciences of California, Inc. (PACB) trades at a Price-to-Sales (P/S) ratio of 2.68.

Question 10

What is Pacific Biosciences of California, Inc.'s Return on Equity (ROE)?

Accepted Answer

Pacific Biosciences of California, Inc. (PACB) has a Return on Equity (ROE) of -1123.27%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	-111.2M	0	-2.7M	-113.9M	-113.9M
2024-12	-206.1M	0	-6.2M	-212.2M	-212.2M
2023-12	-266.5M	0	-8.8M	-275.4M	-275.4M
2022-12	-263.2M	78.6M	-16.9M	-280.1M	-358.8M
2021-12	-111.2M	80.7M	-5.9M	-117.1M	-197.8M

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	-111.2M	0	-2.7M	-113.9M	-113.9M
2024-12	-206.1M	0	-6.2M	-212.2M	-212.2M
2023-12	-266.5M	0	-8.8M	-275.4M	-275.4M
2022-12	-263.2M	78.6M	-16.9M	-280.1M	-358.8M
2021-12	-111.2M	80.7M	-5.9M	-117.1M	-197.8M